HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$55.12
+0.75 (+1.38%)
As of May 10, 9:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.26B
Net Income
155.15M
Gross Margin
56.1%
Profit Margin
12.3%
Rev Growth
+11.1%
D/E Ratio
1.49
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.1% 56.1% 54.3% 54.3%
Operating Margin 16.3% 14.7% 11.5% 11.0%
Profit Margin 12.3% 11.7% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.26B 1.13B 2.17B 1.94B
Gross Profit 706.50M 636.09M 1.18B 1.05B
Operating Income 205.24M 166.31M 248.79M 212.97M
Net Income 155.15M 125.72M 171.22M 125.72M
Gross Margin 56.1% 56.1% 54.3% 54.3%
Operating Margin 16.3% 14.7% 11.5% 11.0%
Profit Margin 12.3% 11.7% 7.9% 6.5%
Rev Growth +11.1% +11.1% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 774.55M 774.55M 666.77M 805.22M
Total Equity 519.10M 519.10M 1.73B 1.53B
D/E Ratio 1.49 1.49 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 249.90M 213.74M 302.84M 250.08M
Free Cash Flow 163.13M 182.49M